I am the clinical medical director of the radiation oncology department at UPMC St. Margaret, with an academic appointment as clinical professor in the University of Pittsburgh medical school. Though I see patients with all types of cancer, I have a special interest in head and neck cancers and prostate cancer, with research interests in these sites, with a concentration in prostate brachytherapy.
Assistant co-director of the radiation oncology residency program at UPMC, preceptor to radiation oncology residents as well as multiple medical students
Benoit RM, Smith RP, Beriwal S. Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy. Clin Oncol (R Coll Radiol). 2014 Dec;26(12):776-80.. Epub 2014 Sep 15. PMID: 25213299
Ling D, Vargo JA, Smith RP. Radiation-induced esophageal strictures in a patient with CREST syndrome. Practical Radiation Oncology. 2015:5-2
Champ CE, Francis L, Clement, RJ, Dickerman R, Smith RP. Fortifying the Treatment of Prostate Cancer with Physical Activity. Prostate Cancer. 2016; 2016 PMID: 26977321.
Smith RP, Beriwal S, Benoit RM. Long Term Rectal Toxicity and Rectal Bleeding Following Cs-131 Prostate Brachytherapy. Submitted for publication
Champ CE, Smith RP. Images in clinical medicine. Radiation recall and woody fibrosis. N Engl J. Med 2015 May 14; 372(20). PMID: 25970071
Research grants and/or contract activity:
Academic grant (along with Dr. Ronald Benoit and Dr. Sushil Beriwal) through Isoray, Inc of $150,000 to conduct research in prostate brachytherapy
Summary of research:
We have ongoing projects looking at various aspects of prostate brachytherapy, with special attention to the use of the Cs-131 isotope and its comparison to I-125. We have published many manuscripts on dosimetry, toxicity and 5 year outcomes of Cs-131 brachytherapy.
In addition, we have an investigator initiated protocol studying focal brachytherapy using Cs-131 for patients with low risk prostate cancer.
I am co-PI on a study assessing activity levels in cancer patients.